Background The purpose of this pilot study was to explore the potential of eye-tracking technology in monitoring symptoms and predicting outcomes in apathetic Alzheimer’s disease (AD) patients treated with methylphenidate (MTP). Methods Neuropsychological tests and eye-tracking measurements were completed at baseline and following at least four weeks of treatment with MTP (5–10 mg BID). Eye-movements were measured while patients viewed novel and social stimuli. Cognition, behavior, and apathy were assessed using the Standardized Mini-Mental State Exam (sMMSE), Neuropsychiatric Inventory, and Apathy Evaluation Scale (AES), respectively. Results Nine patients were included in the analysis (age: median=75, interquartile range=8; sMMSE: median=22, interquartile range=14). Spearman correlations showed that improvement on the AES was associated with increased visual attention towards novel stimuli (ρ7=−0.809, p=.008). Additionally, lower baseline attention towards social images was associated with improvement on the AES (ρ7=0.905, p=.001). Conclusions Eye-tracking techniques can be developed as an objective and nonverbal method of monitoring symptoms and treatment outcomes in AD patients.
Effect of Methylphenidate for Apathy on Visual Attention Scanning Behavior: a Pilot Study
Sarah A. Chau,N. Herrmann,J. Chung,M. Eizenman,K. Lanctôt
Published 2018 in Canadian Geriatrics Journal
ABSTRACT
PUBLICATION RECORD
- Publication year
2018
- Venue
Canadian Geriatrics Journal
- Publication date
2018-06-01
- Fields of study
Medicine, Psychology
- Identifiers
- External record
- Source metadata
Semantic Scholar, PubMed
CITATION MAP
EXTRACTION MAP
CLAIMS
- No claims are published for this paper.
CONCEPTS
- No concepts are published for this paper.
REFERENCES
Showing 1-22 of 22 references · Page 1 of 1
CITED BY
Showing 1-2 of 2 citing papers · Page 1 of 1